The company’s experimental antibody therapy — which was given to President Donald Trump Friday after he was diagnosed with Covid-19 — is still in clinical trials and not yet approved for wider use.
Regeneron Seeks FDA Emergency Approval For Covid-19 Therapy Trump Calls A ‘Cure’
